減量・肥満管理の世界市場予測（～2030年）：製品タイプ、年齢層、機器、サービス、流通チャネル、エンドユーザー、地域別の分析

世界の減量・肥満管理の市場規模は、2023年に2,829億米ドルを占め、予測期間中にCAGR10.1％で成長し、2030年には5,549億米ドルに達すると予想されています。 肥満や過体重の人の減量や体重維持を支援する技術や医薬品は、減量・肥満管理市場に含まれます。

基本的に、肥満は体内の異常な脂肪沈着と蓄積を特徴とする長期的な病状です。肥満度の算出にはBMI（Body Mass Index）が用いられます。減量や肥満に対処するために用いられる方法には、薬物療法、運動療法、栄養補助食品、減量手術などがあります。

健康政策団体Trust for America's Healthが2021年に発表した報告書によると、米国の肥満危機は19州で肥満率が35％を超えていることがわかりました。

増加する肥満率

座りがちなライフスタイル、不健康な食習慣、体重増加を助長する環境要因の急増により、肥満の蔓延は憂慮すべきレベルに達しています。心血管疾患、糖尿病、ある種のがんなど、肥満に伴う健康リスクに対する認識が高まるにつれ、効果的な体重管理ソリューションに対する需要が高まっています。この需要は、生活習慣の改善プログラムから医薬品や外科的処置に至るまで、さまざまな介入の開発と採用を後押ししています。

高い費用

薬、手術、カウンセリング、特殊な食事療法など、減量プログラムに関連する費用は、特に低所得者や健康保険が十分に適用されていない人など、助けを求める個人にとって障壁となり得ます。こうした介入による経済的負担が、専門家の支援を求めたり、処方された治療計画を守ることを躊躇させることも多いです。しかし、減量サービスに包括的な保険が適用されないことが問題をさらに悪化させ、多くの個人が必要不可欠な治療を受ける余裕がないままになっています。その結果、治療へのアクセスにおける格差が拡大し、肥満に関連する健康上の転帰における不平等が永続することになります。

技術の進歩

革新的な技術は、ウェアラブル・フィットネス・トラッカーやモバイル・アプリケーションから、高度な外科技術や薬物介入に至るまで、多様な解決策を提供しています。これらの進歩により、減量や肥満管理のための個別化された的確な戦略が可能となり、個人のニーズや嗜好に応えることができます。デジタルヘルスプラットフォームは、リアルタイムのモニタリング、データ分析、行動追跡を提供し、個人が健康やライフスタイルの選択について十分な情報を得た上で意思決定できるようにします。

効果的な長期的解決策の欠如

数多くの減量介入が存在する一方で、長期にわたって減量を持続させることは、多くの個人にとって依然として大きな課題です。流行のダイエット、サプリメント、一時的なライフスタイルの変化は、初期には結果をもたらすことが多いですが、効果が持続しないことが多いです。このような持続的効果の欠如は消費者の信頼を損ない、市場の成長を妨げます。さらに、肥満は遺伝的、環境的、行動的要因など多因子にわたる原因を持つ複雑な病態であるため、普遍的に有効な治療法の開発が困難です。

COVID-19の影響：

ロックダウン、移動制限、ソーシャルディスタンス措置により、世界中の人々の間で日常生活が乱れ、身体活動が低下し、座りがちな行動が増加しました。ストレス、不安、不確実性が、多くの人々の不健康な食習慣や体重増加をさらに助長しました。逆に、パンデミックを機に健康を優先し、減量目標に集中する人もいました。遠隔医療とバーチャル診察の人気が急上昇し、ヘルスケア専門家や体重管理プログラムへの遠隔アクセスが可能になりました。

予測期間中はフィットネス機器セグメントが最大になる見込み

予測期間中、フィットネス機器セグメントが最大のシェアを占めると予想されます。肥満に伴う健康リスクに対する認識が高まる中、体重管理のための便利で効果的な方法に対する需要が高まっています。トレッドミル、ステーショナリー・バイク、エリプティカル・トレーナー、ウェイト・リフティング・マシンなどのフィットネス機器は、ユーザーの好みや能力に合わせた身体活動に従事するための多彩なオプションを提供します。フィットネス機器のこのアクセシビリティと多用途性は、個人の減量目標達成に向けた積極的なステップに力を与え、それによって市場の成長を促進します。

痩身センターセグメントは予測期間中に最も高いCAGRが見込まれる

痩身センターセグメントは、ダイエット計画、運動ルーチン、多くの場合、医学的監督など、個人のニーズに合わせた個別化された包括的なプログラムを提供するため、予測期間を通じて収益性の高い成長を示すことになる見通しです。健康とフィットネスに対する意識の高まりと肥満の有病率の増加に伴い、減量目標を達成するための専門的な指導とサポートを求めて痩身センターを利用する人が増えています。

最大シェアの地域

予測期間を通じて、アジア太平洋が市場の最大シェアを占める見込みです。肥満が健康に及ぼす悪影響に関する認識が高まるにつれ、個人は特定のニーズや状況に対応したオーダーメイドのソリューションを求めるようになっています。遺伝子検査、カスタマイズされた食事計画、的を絞った運動療法など、個人に合わせたヘルスケア・アプローチは、一般的な治療法に比べてより効果的で持続可能な結果をもたらすため、支持を集めています。さらに、ウェアラブル・フィットネス・デバイスやモバイル・ヘルス・アプリは、個人の進捗状況をモニターし、健康の旅路について十分な情報を得た上で意思決定する力を与えています。

CAGRが最も高い地域：

欧州は、予測期間中に有利な成長を維持する見込みです。これらの地域の個人は所得水準が高くなるにつれて、体重管理や肥満対策など健康とウェルネスを優先する傾向があります。こうした需要の急増は、欧州の減量・肥満管理製品・サービス市場に顕著な影響を与えています。この分野の欧州企業は、発展途上国からの需要増に対応するために事業と流通網を拡大することで、この機会を最大限に活用しています。その結果、こうした要素がこの地域の成長を後押ししています。

無料カスタマイズサービス：

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

• 企業プロファイル
  • 追加市場企業の包括的プロファイリング（3社まで）
  • 主要企業のSWOT分析（3社まで）
• 地域セグメンテーション
  • 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
• 競合ベンチマーキング
  • 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

目次

第1章 エグゼクティブサマリー

第2章 序文

• 概要
• ステークホルダー
• 調査範囲
• 調査手法
  • データマイニング
  • データ分析
  • データ検証
  • 調査アプローチ
• 調査情報源
  • 1次調査情報源
  • 2次調査情報源
  • 前提条件

第3章 市場動向分析

• 促進要因
• 抑制要因
• 機会
• 脅威
• 製品分析
• エンドユーザー分析
• 新興市場
• COVID-19の影響

第4章 ポーターのファイブフォース分析

• 供給企業の交渉力
• 買い手の交渉力
• 代替品の脅威
• 新規参入業者の脅威
• 競争企業間の敵対関係

第5章 世界の減量・肥満管理市場：製品タイプ別

• 薬物
  • 併用薬
  • セロトニン受容体作動薬
  • リパーゼ阻害剤
  • GLP-1受容体作動薬
  • 中枢作用薬
  • その他の薬物
• デバイス
  • 胃電気刺激システム
  • 胃内容排出システム
  • 胃内バルーンシステム
  • 胃バンド
  • 肥満治療用ステープラー器具
  • 他のデバイス
• その他の製品タイプ

第6章 世界の減量・肥満管理市場：年齢層別

• 18歳未満
• 18歳～35歳
• 35歳～50歳
• 50歳超

第7章 世界の減量・肥満管理市場：機器別

• 心血管トレーニング機器
• ジム設備
• 筋力トレーニング機器
• 手術器具
• その他の機器

第8章 世界の減量・肥満管理市場：サービス別

• コンサルティングサービス
• 痩身センター
• フィットネスセンター
• オンライン減量プログラム
• 他のサービス

第9章 世界の減量・肥満管理市場：流通チャネル別

• 小売販売
• 医薬品店
• ハイパーマーケット/スーパーマーケット
• その他の流通チャネル

第10章 世界の減量・肥満管理市場：エンドユーザー別

• 病院
• 外来手術センター
• 減量クリニック
• その他のエンドユーザー

第11章 世界の減量・肥満管理市場：地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン
  • その他欧州
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • ニュージーランド
  • 韓国
  • その他アジア太平洋
• 南米
  • アルゼンチン
  • ブラジル
  • チリ
  • その他南米
• 中東・アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • カタール
  • 南アフリカ
  • その他中東・アフリカ

第12章 主な発展

• 契約、パートナーシップ、コラボレーション、合弁事業
• 買収と合併
• 新製品発売
• 事業拡大
• その他の主要戦略

第13章 企業プロファイリング

• Allergan Plc
• Allurion Technologies Inc
• Amgen Inc
• Apollo Endosurgery, Inc
• Aspire Bariatrics
• Eisai Co., Ltd
• F. Hoffmann-La Roche Ltd
• GlaxoSmithKline plc
• Herbalife International of America, Inc
• Medtronic
• Novo Nordisk A/S
• ReShape Lifesciences, Inc
• Rhythm Pharmaceuticals, Inc
• Takeda Pharmaceutical Company Limited

List of Tables

• Table 1 Global Weight Loss and Obesity Management Market Outlook, By Region (2021-2030) ($MN)
• Table 2 Global Weight Loss and Obesity Management Market Outlook, By Product Type (2021-2030) ($MN)
• Table 3 Global Weight Loss and Obesity Management Market Outlook, By Drugs (2021-2030) ($MN)
• Table 4 Global Weight Loss and Obesity Management Market Outlook, By Combination Drugs (2021-2030) ($MN)
• Table 5 Global Weight Loss and Obesity Management Market Outlook, By Serotonin Receptor Agonists (2021-2030) ($MN)
• Table 6 Global Weight Loss and Obesity Management Market Outlook, By Lipase Inhibitors (2021-2030) ($MN)
• Table 7 Global Weight Loss and Obesity Management Market Outlook, By GLP-1 Receptor Agonists (2021-2030) ($MN)
• Table 8 Global Weight Loss and Obesity Management Market Outlook, By Centrally Acting Drugs (2021-2030) ($MN)
• Table 9 Global Weight Loss and Obesity Management Market Outlook, By Other Drugs (2021-2030) ($MN)
• Table 10 Global Weight Loss and Obesity Management Market Outlook, By Devices (2021-2030) ($MN)
• Table 11 Global Weight Loss and Obesity Management Market Outlook, By Gastric Electrical Stimulation Systems (2021-2030) ($MN)
• Table 12 Global Weight Loss and Obesity Management Market Outlook, By Gastric Emptying Systems (2021-2030) ($MN)
• Table 13 Global Weight Loss and Obesity Management Market Outlook, By Gastric Balloon Systems (2021-2030) ($MN)
• Table 14 Global Weight Loss and Obesity Management Market Outlook, By Gastric Bands (2021-2030) ($MN)
• Table 15 Global Weight Loss and Obesity Management Market Outlook, By Bariatric Stapling Devices (2021-2030) ($MN)
• Table 16 Global Weight Loss and Obesity Management Market Outlook, By Other Devices (2021-2030) ($MN)
• Table 17 Global Weight Loss and Obesity Management Market Outlook, By Other Product Types (2021-2030) ($MN)
• Table 18 Global Weight Loss and Obesity Management Market Outlook, By Age Group (2021-2030) ($MN)
• Table 19 Global Weight Loss and Obesity Management Market Outlook, By Under 18 Years (2021-2030) ($MN)
• Table 20 Global Weight Loss and Obesity Management Market Outlook, By 18 To 35 Years (2021-2030) ($MN)
• Table 21 Global Weight Loss and Obesity Management Market Outlook, By 35 To 50 Years (2021-2030) ($MN)
• Table 22 Global Weight Loss and Obesity Management Market Outlook, By Above 50 Years (2021-2030) ($MN)
• Table 23 Global Weight Loss and Obesity Management Market Outlook, By Equipment (2021-2030) ($MN)
• Table 24 Global Weight Loss and Obesity Management Market Outlook, By Cardiovascular Training Equipment (2021-2030) ($MN)
• Table 25 Global Weight Loss and Obesity Management Market Outlook, By Fitness Equipment (2021-2030) ($MN)
• Table 26 Global Weight Loss and Obesity Management Market Outlook, By Strength Training Equipment (2021-2030) ($MN)
• Table 27 Global Weight Loss and Obesity Management Market Outlook, By Surgical Equipment (2021-2030) ($MN)
• Table 28 Global Weight Loss and Obesity Management Market Outlook, By Other Equipments (2021-2030) ($MN)
• Table 29 Global Weight Loss and Obesity Management Market Outlook, By Service (2021-2030) ($MN)
• Table 30 Global Weight Loss and Obesity Management Market Outlook, By Consulting Services (2021-2030) ($MN)
• Table 31 Global Weight Loss and Obesity Management Market Outlook, By Slimming Centers (2021-2030) ($MN)
• Table 32 Global Weight Loss and Obesity Management Market Outlook, By Fitness Centers (2021-2030) ($MN)
• Table 33 Global Weight Loss and Obesity Management Market Outlook, By Online Weight Loss Programs (2021-2030) ($MN)
• Table 34 Global Weight Loss and Obesity Management Market Outlook, By Other Services (2021-2030) ($MN)
• Table 35 Global Weight Loss and Obesity Management Market Outlook, By Distribution Channel (2021-2030) ($MN)
• Table 36 Global Weight Loss and Obesity Management Market Outlook, By Retail Sales (2021-2030) ($MN)
• Table 37 Global Weight Loss and Obesity Management Market Outlook, By Pharmaceutical Stores (2021-2030) ($MN)
• Table 38 Global Weight Loss and Obesity Management Market Outlook, By Hypermarket/ Supermarket (2021-2030) ($MN)
• Table 39 Global Weight Loss and Obesity Management Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
• Table 40 Global Weight Loss and Obesity Management Market Outlook, By End User (2021-2030) ($MN)
• Table 41 Global Weight Loss and Obesity Management Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 42 Global Weight Loss and Obesity Management Market Outlook, By Ambulatory Surgery Centres (2021-2030) ($MN)
• Table 43 Global Weight Loss and Obesity Management Market Outlook, By Weight Loss Clinics (2021-2030) ($MN)
• Table 44 Global Weight Loss and Obesity Management Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

According to Stratistics MRC, the Global Weight Loss and Obesity Management Market is accounted for $282.9 billion in 2023 and is expected to reach $554.9 billion by 2030 growing at a CAGR of 10.1% during the forecast period. Technologies and drugs that assist obese or overweight people in losing weight or maintaining their weight are included in the weight loss and obesity management market. Fundamentally, obesity is a long-term medical condition characterized by abnormal fat deposition and accumulation in the body. The Body Mass Index, or BMI, is used to compute it. Some of the methods used to address weight loss and obesity include medications, exercise, nutritional supplements, and weight reduction surgery.

According to a report published by Trust for America's Health, a health policy organization, in 2021, the nation's obesity crisis found that 19 states have obesity rates over 35 percent in U.S.

Market Dynamics:

Driver:

Increasing obesity rates

With a surge in sedentary lifestyles, unhealthy dietary habits, and environmental factors conducive to weight gain, the prevalence of obesity has reached alarming levels. As individuals become increasingly aware of the health risks associated with obesity, including cardiovascular diseases, diabetes, and certain types of cancer, there is a growing demand for effective weight management solutions. This demand fuels the development and adoption of various interventions, ranging from lifestyle modification programs to pharmaceuticals and surgical procedures.

Restraint:

High costs

The expenses associated with weight loss programs, including medications, surgery, counseling, and specialized diets, can pose a barrier to individuals seeking help, particularly those with lower incomes or inadequate health insurance coverage. The financial burden of these interventions often deters individuals from pursuing professional assistance or adhering to prescribed treatment plans. However, the lack of comprehensive insurance coverage for weight loss services further exacerbates the issue, leaving many individuals unable to afford essential treatments. As a result, disparities in access to care widen, perpetuating inequalities in health outcomes related to obesity.

Opportunity:

Technological advancements

Innovative technologies offer diverse solutions, ranging from wearable fitness trackers and mobile applications to advanced surgical techniques and pharmaceutical interventions. These advancements enable personalized and precise strategies for weight loss and obesity management, catering to individual needs and preferences. Digital health platforms provide real-time monitoring, data analysis, and behavior tracking, empowering individuals to make informed decisions about their health and lifestyle choices.

Threat:

Lack of effective long-term solutions

While numerous weight loss interventions exist, sustaining weight loss over the long term remains a significant challenge for many individuals. Fad diets, supplements and temporary lifestyle changes often yield initial results, but they frequently fail to provide lasting benefits. This lack of sustained efficacy undermines consumer confidence and hinders the growth of the market. Moreover, obesity is a complex condition with multifactorial causes, including genetic, environmental, and behavioral factors, making it difficult to develop universally effective treatments.

Covid-19 Impact:

Lockdowns, restrictions on movement, and social distancing measures led to disrupted routines, reduced physical activity, and increased sedentary behavior among populations worldwide. Stress, anxiety, and uncertainty further contributed to unhealthy eating habits and weight gain for many individuals. Conversely, some individuals used the pandemic as an opportunity to prioritize their health and focus on weight loss goals. Telehealth and virtual consultations surged in popularity, enabling remote access to healthcare professionals and weight management programs.

The fitness equipment segment is expected to be the largest during the forecast period

Fitness Equipment segment is expected to hold the largest share during the forecast period. With the rising awareness of the health risks associated with obesity, there's an increasing demand for convenient and effective ways to manage weight. Fitness equipment such as treadmills, stationary bikes, elliptical trainers, and weight lifting machines provide users with versatile options for engaging in physical activity tailored to their preferences and abilities. This accessibility and versatility of fitness equipment empower individuals to take proactive steps towards achieving their weight loss goals, thereby driving growth within the market.

The slimming centers segment is expected to have the highest CAGR during the forecast period

Slimming Centers segment is positioned to witness the profitable growth throughout the overcast period as it offers personalized, comprehensive programs tailored to individual needs, including diet plans, exercise routines, and often, medical supervision. With rising awareness about health and fitness, coupled with the increasing prevalence of obesity, more people are turning to slimming centers for professional guidance and support in achieving their weight loss goals.

Region with largest share:

Asia Pacific region dominated the largest share of the market throughout the estimated period. As awareness grows regarding the adverse effects of obesity on health, individuals are seeking tailored solutions that cater to their specific needs and circumstances. Personalized healthcare approaches, such as genetic testing, customized diet plans, and targeted exercise regimens, are gaining traction as they offer more effective and sustainable results compared to generic treatments. Moreover, wearable fitness devices and mobile health apps, empower individuals to monitor their progress and make informed decisions about their health journey.

Region with highest CAGR:

Europe region is poised to hold lucrative growth over the projection period. As individuals in these regions attain higher levels of income, they tend to prioritize health and wellness, including efforts to manage weight and combat obesity. This burgeoning demand has had a notable impact on the European market for weight loss and obesity management products and services. European companies in this sector are capitalizing on the opportunity by expanding their operations and distribution networks to cater to the growing demand from developing countries. As a result, these elements are boosting the regional growth.

Key players in the market

Some of the key players in Weight Loss and Obesity Management market include Allergan Plc, Allurion Technologies Inc, Amgen Inc, Apollo Endosurgery, Inc, Aspire Bariatrics, Eisai Co., Ltd, F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Herbalife International of America, Inc, Medtronic, Novo Nordisk A/S, ReShape Lifesciences, Inc, Rhythm Pharmaceuticals, Inc and Takeda Pharmaceutical Company Limited.

Key Developments:

In March 2023, PRISTYN CARE, a healthcare service provider, announced that it has entered into a strategic partnership with Allurion, a company developing a medical device for weight loss, in order to offer a weight-loss and obesity care platform.

In December 2022, Amgen Inc., announced new Phase 1 data from AMG 133, a novel bispecific glucose-dependent insulinotropic polypeptide receptor (GIPR) antagonist and glucagon-like peptide-1 (GLP-1) receptor agonist molecule. This first-in-human study was designed to evaluate the safety, tolerability, pharmacokinetic, and pharmacodynamic effects of AMG 133 in people with obesity and without diabetes.

Product Types Covered:

• Drugs
• Devices
• Other Product Types

Age Groups Covered:

• Under 18 Years
• 18 To 35 Years
• 35 To 50 Years
• Above 50 Years

Equipments Covered:

• Cardiovascular Training Equipment
• Fitness Equipment
• Strength Training Equipment
• Surgical Equipment
• Other Equipments

Services Covered:

• Consulting Services
• Slimming Centers
• Fitness Centers
• Online Weight Loss Programs
• Other Services

Distribution Channels Covered:

• Retail Sales
• Pharmaceutical Stores
• Hypermarket/ Supermarket
• Other Distribution Channels

End Users Covered:

• Hospitals
• Ambulatory Surgery Centres
• Weight Loss Clinics
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 End User Analysis
• 3.8 Emerging Markets
• 3.9 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Weight Loss and Obesity Management Market, By Product Type

• 5.1 Introduction
• 5.2 Drugs
  • 5.2.1 Combination Drugs
  • 5.2.2 Serotonin Receptor Agonists
  • 5.2.3 Lipase Inhibitors
  • 5.2.4 GLP-1 Receptor Agonists
  • 5.2.5 Centrally Acting Drugs
  • 5.2.6 Other Drugs
• 5.3 Devices
  • 5.3.1 Gastric Electrical Stimulation Systems
  • 5.3.2 Gastric Emptying Systems
  • 5.3.3 Gastric Balloon Systems
  • 5.3.4 Gastric Bands
  • 5.3.5 Bariatric Stapling Devices
  • 5.3.6 Other Devices
• 5.4 Other Product Types

6 Global Weight Loss and Obesity Management Market, By Age Group

• 6.1 Introduction
• 6.2 Under 18 Years
• 6.3 18 To 35 Years
• 6.4 35 To 50 Years
• 6.5 Above 50 Years

7 Global Weight Loss and Obesity Management Market, By Equipment

• 7.1 Introduction
• 7.2 Cardiovascular Training Equipment
• 7.3 Fitness Equipment
• 7.4 Strength Training Equipment
• 7.5 Surgical Equipment
• 7.6 Other Equipments

8 Global Weight Loss and Obesity Management Market, By Service

• 8.1 Introduction
• 8.2 Consulting Services
• 8.3 Slimming Centers
• 8.4 Fitness Centers
• 8.5 Online Weight Loss Programs
• 8.6 Other Services

9 Global Weight Loss and Obesity Management Market, By Distribution Channel

• 9.1 Introduction
• 9.2 Retail Sales
• 9.3 Pharmaceutical Stores
• 9.4 Hypermarket/ Supermarket
• 9.5 Other Distribution Channels

10 Global Weight Loss and Obesity Management Market, By End User

• 10.1 Introduction
• 10.2 Hospitals
• 10.3 Ambulatory Surgery Centres
• 10.4 Weight Loss Clinics
• 10.5 Other End Users

11 Global Weight Loss and Obesity Management Market, By Geography

• 11.1 Introduction
• 11.2 North America
  • 11.2.1 US
  • 11.2.2 Canada
  • 11.2.3 Mexico
• 11.3 Europe
  • 11.3.1 Germany
  • 11.3.2 UK
  • 11.3.3 Italy
  • 11.3.4 France
  • 11.3.5 Spain
  • 11.3.6 Rest of Europe
• 11.4 Asia Pacific
  • 11.4.1 Japan
  • 11.4.2 China
  • 11.4.3 India
  • 11.4.4 Australia
  • 11.4.5 New Zealand
  • 11.4.6 South Korea
  • 11.4.7 Rest of Asia Pacific
• 11.5 South America
  • 11.5.1 Argentina
  • 11.5.2 Brazil
  • 11.5.3 Chile
  • 11.5.4 Rest of South America
• 11.6 Middle East & Africa
  • 11.6.1 Saudi Arabia
  • 11.6.2 UAE
  • 11.6.3 Qatar
  • 11.6.4 South Africa
  • 11.6.5 Rest of Middle East & Africa

12 Key Developments

• 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 12.2 Acquisitions & Mergers
• 12.3 New Product Launch
• 12.4 Expansions
• 12.5 Other Key Strategies

13 Company Profiling

• 13.1 Allergan Plc
• 13.2 Allurion Technologies Inc
• 13.3 Amgen Inc
• 13.4 Apollo Endosurgery, Inc
• 13.5 Aspire Bariatrics
• 13.6 Eisai Co., Ltd
• 13.7 F. Hoffmann-La Roche Ltd
• 13.8 GlaxoSmithKline plc
• 13.9 Herbalife International of America, Inc
• 13.10 Medtronic
• 13.11 Novo Nordisk A/S
• 13.12 ReShape Lifesciences, Inc
• 13.13 Rhythm Pharmaceuticals, Inc
• 13.14 Takeda Pharmaceutical Company Limited